Roseburia intestinalis and its metabolite butyrate inhibit colitis and upregulate tlr5 through the sp3 signaling pathway

HIGHLIGHTS

  • who: Guangcong Ruan and colleagues from the Department of Gastroenterology, Daping Hospital, Army Medical University (Third Military Yinchuan, China have published the research: Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway, in the Journal: Nutrients 2022, 14, 3041. of /2022/
  • what: The authors investigated the role of R. and Toll-like receptor 5 (TLR5) in relieving mouse This work provides new insight into the anti-inflammatory effects of R. in and a potential target for UC prevention and treatment. This study proposes that the one of the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?